this post was submitted on 26 Dec 2025
2 points (100.0% liked)

China News

91 readers
2 users here now

A community for china news

founded 3 months ago
MODERATORS
 

Chinese drugmakers have signed a late-year burst of out-licensing agreements with overseas partners, underlining China’s growing role as a source of novel medicines as multinational pharma groups hunt for new assets. Jacobio Pharmaceuticals said it expected to receive an upfront payment of US$100 million from AstraZeneca, according to a filing to the Hong Kong stock exchange on December 21. The British-Swedish drugmaker was paying for exclusive rights to research, develop, register, manufacture...


From China - South China Morning Post via This RSS Feed.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here